
The American College of Cardiology has cancelled its upcoming ACC.20 event with the World Congress of Cardiology due to concerns …

Pharmacovigilance is a critical function in ensuring public health, but is our current system built to tackle the challenges of …

The British Government has outlined its emergency legislation to tackle coronavirus in which people could leave work to become volunteers …

The FDA has moved to approve its first therapy to directly treat the overproduction of the hormone cortisol which is …

Eli Lilly is asking some of its employees to work from home to stop the spread of coronavirus on its …

Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of …

NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 …

The coronavirus continues to threaten the global drug supply line, with disruption to the US drug production pipeline from the …

Chimeric antigen receptor T cell (CAR-T) therapy has gained much traction and attention in the past years for its innovative …

A cross-party group of MPs have said that those with HIV do not have access to adequate mental health treatment. …

New Phase 3 has been released by AstraZeneca, showing that the PD-L1 inhibitor Imfinzi (durvalumab), when combined with tremelimumab, failed …

The Drug Controller General of India (DCGI) has approved the marketing application for Zydus Cadila’s saroglitazar to treat patients with …

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …

The coronavirus has continued to spread across the UK as health officials announce they have moved into the second stage …

China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in …

Allergan and Editas Medicine have treated their first patient in a clinical trial with CRISPR gene editing. This therapy is …

The nest cost of prescription drugs rose over three times faster than the rate of inflation over the course of …

Takeda’s Alunbrig (brigatinib) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …

Large pharmaceutical companies make a much larger profit than most other public companies, according to a new study. The research …

India is set to reduce exports of active pharmaceutical ingredients (APIs) until further notice, due to fears of internal drug …